Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Ending Cash Balance (2022 - 2026)

Updated

Analysis

Adaptin Bio (APTN) Ending Cash Balance (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 670,488.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 670,488.00
Mar 31, 2026 301,309.00
Dec 31, 2025 459,174.00
Sep 30, 2025 579,089.00
Jun 30, 2025 1.35 Mn
Mar 31, 2025 2.37 Mn
Dec 31, 2024 34,085.00
Sep 30, 2024 115,308.00
Jun 30, 2024 23,776.00
Mar 31, 2024 5,059.00
Dec 31, 2023 4,754.00
Sep 30, 2023 380.00
Dec 31, 2022 500.00
API Access

Adaptin Bio Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=APTN&period=max&api_key=YOUR_API_KEY